Travel medicine and the solid organ transplant recipient

American Journal of Transplantation

Volumn 9, Issue SUPPL. 4, 2009, Pages

  Kotton, C N ^a,b   Hibberd, P L ^c,d,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e Medicine and Public Health   (United States)

Author keywords

Solid organ transplant; Travel medicine; Vaccinations; Vaccines

Indexed keywords

ANTIDIARRHEAL AGENT; ANTIMALARIAL AGENT; BCG VACCINE; BISMUTH SALICYLATE; CHICKENPOX VACCINE; CHLOROQUINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; DOXYCYCLINE; HAEMOPHILUS VACCINE; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; ROTAVIRUS VACCINE; SMALLPOX VACCINE; STREPTOCOCCUS VACCINE; TYPHOID VACCINE; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; CHICKENPOX; CLINICAL PROTOCOL; DENGUE; DIARRHEA; DIPHTHERIA; ENCEPHALOMYELITIS; EPIDEMIC ENCEPHALITIS; GRAFT RECIPIENT; HEPATITIS A; HEPATITIS B; HUMAN; HYPERSENSITIVITY REACTION; IMMUNIZATION; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INFECTION PREVENTION; INFLUENZA; LUNG TUBERCULOSIS; MALARIA; MEASLES; MENINGOCOCCOSIS; MUMPS; NEISSERIA MENINGITIDIS; ORAL REHYDRATION THERAPY; ORGAN TRANSPLANTATION; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; RABIES; REVIEW; RUBELLA; SALMONELLA ENTERICA; SALMONELLA TYPHI; SKIN CANCER; SMALLPOX; STREPTOCOCCUS INFECTION; TETANUS; TRAVEL; TYPHOID FEVER; URTICARIA; VERRUCA VULGARIS; VIRUS INFECTION; WART VIRUS; YELLOW FEVER;

ADULT; HUMANS; ORGAN TRANSPLANTATION; TRAVEL MEDICINE; VACCINES;

EID: 72949104738     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02920.x     Document Type: Review

References (50)

1. Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004 11 : 37 43.
2. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation 2008 86 : 407 412.
3. Roukens AH, van Dissel JT, de Fijter JW, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant 2007 21 : 567 570.
4. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007 357 : 2601 2614.
5. Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007 298 : 2155 2163.
6. Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA 1997 277 : 1148 1151.
7. http://www.cdc.gov/vaccines/recs/schedules/adult-schedule.htm.2007-2008.
8. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant 2008 8 : 9 14.
9. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004 4 : 160 163.
10. Ballout A, Goffin E, Yombi JC, Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc 2005 37 : 2826 2827.
11. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin Microbiol Rev 2003 16 : 357 364.
12. The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007 33 : 1 24.
13. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005 5 : 8 14.
14. Kumar D, Welsh B, Siegal D, Chen MH, Humar A. Immunogenicity of pneumococcal vaccine in renal transplant recipients-three year follow-up of a randomized trial. Am J Transplant 2007 7 : 633 638.
15. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001 33 : S15 S21.
16. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001 15 : 273 305, xii.
17. Health Information for International Travel 2003-2004. Atlanta, Georgia : Centers for Disease Control, Department of Health and Human Services, 2003.
18. Hata A, Asanuma H, Rinki M et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002 347 : 26 34.
19. Hayney MS, Welter DL, Reynolds AM, Francois M, Love RB. High-dose hepatitis B vaccine in patients waiting for lung transplantation. Pharmacotherapy 2003 23 : 555 560.
20. Bienzle U, Gunther M, Neuhaus R et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003 38 : 811 819.
21. Choy BY, Peiris JS, Chan TM, Lo SK, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transplant 2002 2 : 965 969.
22. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med 2000 342 : 1716 1725.
23. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001 72 : 272 276.
24. Dumot JA, Barnes DS, Younossi Z et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999 94 : 1601 1604.
25. Stark K, Gunther M, Neuhaus R et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999 180 : 2014 2017.
26. Gunther M, Stark K, Neuhaus R, Reinke P, Schroder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation 2001 71 : 477 479.
27. Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 2007 25 : 927 931.
28. http://www.who.int/vaccine-research/diseases/diarrhoeal/en/index7.html.
29. Lin PL, Michaels MG, Green M et al. Safety and immunogenicity of the American Academy of Pediatrics-recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Pediatrics 2005 116 : 160 167.
30. Kennedy SE, Shen Y, Charlesworth JA et al. Outcome of overseas commercial kidney transplantation: An Australian perspective. Med J Aust 2005 182 : 224 227.
31. Cetron MS, Marfin AA, Julian KG et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002 51 : 1 11.
32. Fishman JA. Smallpox and live-virus vaccination in transplant recipients. Am J Transplant 2003 3 : 786 793.
33. Ljungman P. Vaccination of Transplant Recipients. In : Bowden RA, PL, Paya CV, eds. Transplant Infections. Philadelphia, Lippincott Williams & Wilkins, 2003 : 611 624.
34. Mileno M. Preparation of Immunocompromised Travelers. In : Keystone JS, PK, Freedman DP, Nothdurft HD, Connor BA, eds. Travel Medicine, 1st Ed. Edinburgh, Mosby, 2004 : 249 255.
35. Gowda R, Cartwright K, Bremner JA, Green ST. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004 72 : 299 301.
36. Receveur MC, Thiebaut R, Vedy S, Malvy D, Mercie P, Bras ML. Yellow fever vaccination of human immunodeficiency virus-infected patients: Report of 2 cases. Clin Infect Dis 2000 31 : E7 E8.
37. Tattevin P, Depatureaux AG, Chapplain JM et al. Yellow fever vaccine is safe and effective in HIV-infected patients. AIDS 2004 18 : 825 827.
38. Ho YL, Enohata T, Lopes MH, De Sousa Dos Santos S. Vaccination in Brazilian HIV-Infected Adults: A Cross-Sectional Study. AIDS Patient Care STDS 2007
39. Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 2002 85 : 131 134.
40. Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA 2001 285 : 1574 1575.
41. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993 42 : 1 15.
42. Child & Adolescent Immunization Schedules. Centers for Disease Control and Prevention 2008. Available from : http://www.cdc.gov/vaccines/recs/ schedules/child-schedule.htm. Accessed December 27, 2008.
43. Shinjoh M, Miyairi I, Hoshino K, Takahashi T, Nakayama T. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine 2008 26 : 6859 6863.
44. Khan S, Erlichman J, Rand EB. Live virus immunization after orthotopic liver transplantation. Pediatr Transplant 2006 10 : 78 82.
45. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993 123 : 87 89.
46. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 56 : 1 40.
47. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis 2002 35 : 1088 1095.
48. Conlon CP. The Immunocompromised Traveler. In : DuPont HL, Steffer R, eds. Textbook of Travel Medicine and Health. 2nd Ed. B.C. Decker, 2001 : 464 469.
49. Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001 345 : 107 114.
50. Advising Travelers with Specific Needs: The Immunocompromised Traveler. Available from : http://wwwnc.cdc.gov/travel/yellowbook/2010/chapter-8/ immunocompromised-traveler.aspx. Accessed November 12, 2009.